ebook Munafa Stock Market Course + Intraday & FNO calls  

       

506235 announcements Alembic Ltd. announcements and dividends declared BSE

Alembic Ltd. Complete list of announcements declared & dividend announcements by Alembic Ltd. 506235

Alembic Ltd. 506235 listed on BSE and deals in

Announcements and dividends declared by Alembic Ltd. 506235

Alembic Pharmaceuticals receives USFDA approval (final & tentative) for 11 products
Alembic Pharmaceuticals has received 11 US Food & Drug Administration (USFDA) Product Approvals (Final & Tentative) during the quarter ended 30 June 2024. The products and indication is summarized as under:
Announcement as on 03 July 2024

Alembic Pharmaceuticals receives USFDA approval for Dabigatran Etexilate Capsules
Alembic Pharmaceuticals (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Dabigatran Etexilate Capsules, 75 mg and 150 mg and Tentative approval
Announcement as on 18 June 2024

Alembic Pharma gets USFDA nod for Dabigatran Etexilate capsules
Alembic Pharmaceuticals Ltd received final approval from the US health regulator for generic Dabigatran Etexilate capsules 75 mg and 150 mg to reduce stroke and blood clots in adults with a specific medical condition.
Announcement as on 18 June 2024

Alembic Pharma gets USFDA nod for generic injection to treat hereditary angioedema
The approval by the US Food & Drug Administration (USFDA) is for the Abbreviated New Drug Application (ANDA) for Icatibant injection of strengths 30 mg/3 mL (10 mg/mL) single-dose prefilled syringe, Alembic Pharmaceuticals said in a regulatory filing.
Announcement as on 17 June 2024

Alembic gets USFDA nod for generic injection to treat hereditary angioedema
Alembic Pharmaceuticals Ltd on Monday said it has received final approval from the US health regulator for its generic Icatibant injection indicated for the treatment of acute attacks of hereditary angioedema in adults. The approval by the US Food & Drug A
Announcement as on 17 June 2024

Announcements by Alembic Ltd. first page | Next page | Prev page |

506235 Alembic Ltd. current price & indicator signals

Moving Averages for Alembic Ltd.

  • 5Day Average: 97.54
  • 12Day Average: 92.57
  • 20Day Average: 90.32
  • 50Day Average: 90.3
  • 100Day Average: 89.63
  • 150Day Average: 89.34
  • 200Day Average: 92

506235 Indicators & signals

Indicator MACD (12,26,9)

94.29, 91.66, 1.06
Indicator MACD is in positive zone

Indicator ADX (14)

60.81, 34, 8.29
Indicator ADX is indicating that momentum is still strong.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 63
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 506235 Alembic Ltd. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
28 Fri Aug 2026 100.15 99.62 to 102.97 -2.4% 0.62 times
27 Thu Aug 2026 102.61 97.91 to 104.38 4% 2.02 times
26 Wed Aug 2026 98.66 92.36 to 99.47 4.21% 1.25 times
25 Tue Aug 2026 94.67 90.90 to 96.93 3.34% 1.87 times
24 Mon Aug 2026 91.61 91.19 to 93.93 -1.21% 0.32 times
21 Fri Aug 2026 92.73 90.60 to 93.19 1.42% 0.63 times
20 Thu Aug 2026 91.43 87.25 to 92.50 3.05% 0.84 times
19 Wed Aug 2026 88.72 87.98 to 90.03 -1.08% 0.32 times
18 Tue Aug 2026 89.69 88.00 to 90.55 -0.4% 0.57 times
17 Mon Aug 2026 90.05 85.81 to 90.50 3.83% 0.81 times
14 Fri Aug 2026 86.73 82.75 to 87.64 3.57% 1.39 times
13 Thu Aug 2026 83.74 83.39 to 84.88 -1.4% 0.11 times

Videos related to: 506235 announcements Alembic Ltd. announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

506235 announcements Alembic Ltd. announcements and dividends declared BSE

 

Back to top